Advanced search
Publication Cover
Clinical Ophthalmology Volume 15, 2021 - Issue
Submit an article Journal homepage
365
Views
7
CrossRef citations to date
0
Altmetric
Original Research

Real-World Experience with Lifitegrast Ophthalmic Solution (Xiidra®) in the US and Canada: Retrospective Study of Patient Characteristics, Treatment Patterns, and Clinical Effectiveness in 600 Patients with Dry Eye Disease

John A Hovanesian1 Harvard Eye Associates, Laguna Hills, CA, USA;2 UCLA Jules Stein Eye Institute, Los Angeles, CA, USAORCID Iconhttps://orcid.org/0000-0001-8060-8750
ORCID Icon,
Kelly K Nichols3 School of Optometry, University of Alabama at Birmingham, Birmingham, AL, USAORCID Iconhttps://orcid.org/0000-0003-2937-1457
ORCID Icon,
Mitchell Jackson4 Jacksoneye, Lake Villa, IL, USAORCID Iconhttps://orcid.org/0000-0002-7591-921X
ORCID Icon,
James Katz5 The Midwest Center for Sight, Des Plaines, IL, USA
,
Arthur Chan6 Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA
,
Mrudula B Glassberg6 Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA
,
Brigitte Sloesen7 Novartis Pharma AG, Basel, Switzerland
,
Caroline Korves8 Analysis Group, Inc., Boston, MA, USAORCID Iconhttps://orcid.org/0000-0001-8598-5176
ORCID Icon,
Catherine Nguyen9 Analysis Group, Inc., Los Angeles, CA, USA
&
Annie Syntosi7 Novartis Pharma AG, Basel, SwitzerlandCorrespondence[email protected]
 show all
Pages 1041-1054 | Published online: 08 Mar 2021

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Wenyan Peng, Xiuying Jiang, Lei Zhu, Xiaofeng Li, Qizhi Zhou, Ying Jie, Zhipeng You, Miaoqin Wu, Xiuming Jin, Xiaoyi Li & Shiyou Zhou. (2022) Cyclosporine A (0.05%) Ophthalmic Gel in the Treatment of Dry Eye Disease: A Multicenter, Randomized, Double-Masked, Phase III, COSMO Trial. Drug Design, Development and Therapy 16, pages 3183-3194.
Read now

Articles from other publishers (6)

Matthew T. Hirabayashi & Brad P. Barnett. (2023) Solving STODS—Surgical Temporary Ocular Discomfort Syndrome. Diagnostics 13:5, pages 837.
Crossref
Kevin Y. Wu, Wei T. Chen, Y-Kim Chu-Bédard, Gauri Patel & Simon D. Tran. (2022) Management of Sjogren’s Dry Eye Disease—Advances in Ocular Drug Delivery Offering a New Hope. Pharmaceutics 15:1, pages 147.
Crossref
Noriaki Nagai & Hiroko Otake. (2022) Novel drug delivery systems for the management of dry eye. Advanced Drug Delivery Reviews 191, pages 114582.
Crossref
Jing-Xing Li, Yi-Yu Tsai, Chun-Ting Lai, You-Ling Li, Ying-Hsuen Wu & Chun-Chi Chiang. (2022) Lifitegrast Ophthalmic Solution 5% Is a Safe and Efficient Eyedrop for Dry Eye Disease: A Systematic Review and Meta-Analysis. Journal of Clinical Medicine 11:17, pages 5014.
Crossref
Gerd Geerling, Samer Hamada, Stefan Trocmé, Sten Ræder, Xiangjun Chen, Claudia Fassari & Ines Lanzl. (2022) Real-World Effectiveness, Tolerability and Safety of Cyclosporine A 0.1% Cationic Emulsion in Severe Keratitis and Dry Eye Treatment. Ophthalmology and Therapy 11:3, pages 1101-1117.
Crossref
Jiawei Ling, Ben Chung-Lap Chan, Miranda Sin-Man Tsang, Xun Gao, Ping Chung Leung, Christopher Wai-Kei Lam, Jiang-Miao Hu & Chun Kwok Wong. (2022) Current Advances in Mechanisms and Treatment of Dry Eye Disease: Toward Anti-inflammatory and Immunomodulatory Therapy and Traditional Chinese Medicine. Frontiers in Medicine 8.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.